06.10.2019

Cerenion awarded first key patents on its brain monitoring technology

The European Intellectual Property Office (EUIPO) and the U.S. Patent and Trademark Office (USPTO) have separately awarded Cerenion Oy patents related to its novel measure of brain condition and function.
The patents, also accompanied by an awarded worldwide PCT-extension, cover key aspects of the Cerenion C-Trend® technology. The patents provide protection for the novel intellectual property behind the next-generation brain monitoring technology.
"These patents recognize the great value of our technology, and provide us with a solid foundation for moving towards product launch on the international marketplace", says Dr. Jukka Kortelainen, Chief Medical Officer and head of IPR Management at Cerenion.
Cerenion Oy has filed multiple intellectual property applications on its technology worldwide.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
HELSINKI
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
FINLAND
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2021 Cerenion Oy